DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Clarke N, Wiechno P, Alekseev B. et al.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet Oncology 2018;
19: 975-986
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.